Deal Watch: Fresenius Drops Bid For Akorn, Citing Data-Integrity Concerns
Executive Summary
Janssen and Bristol team to develop next-generation oral anticoagulant, while UCB buys Proximagen's nasal spray candidate and Duke spinout focused on genomics.